97 related articles for article (PubMed ID: 12947554)
1. [Expression of Fas, FasL and IFN-gamma in gastric cancer].
Li Z; Wang Z; Zhao Z; Zhang Y; Ke Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):386-9. PubMed ID: 12947554
[TBL] [Abstract][Full Text] [Related]
2. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F
Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of Fas and FasL protein expression in gastric carcinoma and local lymph node tissues.
Li Q; Peng J; Li XH; Liu T; Liang QC; Zhang GY
World J Gastroenterol; 2010 Mar; 16(10):1274-8. PubMed ID: 20222173
[TBL] [Abstract][Full Text] [Related]
4. Fas (Apo-1/CD95) and Fas ligand interaction between gastric cancer cells and immune cells.
Lee TB; Min YD; Lim SC; Kim KJ; Jeon HJ; Choi SM; Choi CH
J Gastroenterol Hepatol; 2002 Jan; 17(1):32-8. PubMed ID: 11895550
[TBL] [Abstract][Full Text] [Related]
5. The distribution and intracellular location of Fas and Fas Ligand following gastric carcinogenesis: Fas Ligand expressing gastric carcinoma cells can inhibit local immune response.
Liu H; Ubukata H; Tabuchi T; Nakachi T; Nagata H; Shimazaki J; Motohashi G; Konishi S; Nishimura M; Satani T; Hong J; Nakada I; Saniabadi AR; Tabuchi T
Mol Cell Biochem; 2009 Nov; 331(1-2):181-6. PubMed ID: 19458913
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma.
He D; Xiao L; Chen JN; Liang Q; Shao CK
Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111
[TBL] [Abstract][Full Text] [Related]
7. Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer.
Zheng HC; Sun JM; Wei ZL; Yang XF; Zhang YC; Xin Y
World J Gastroenterol; 2003 Jul; 9(7):1415-20. PubMed ID: 12854132
[TBL] [Abstract][Full Text] [Related]
8. Correlation between Fas and FasL proteins expression in normal gastric mucosa and gastric cancer.
Gryko M; Guzińska-Ustymowicz K; Pryczynicz A; Cepowicz D; Kukliński A; Czyżewska J; Kemona A; Kędra B
Folia Histochem Cytobiol; 2011; 49(1):142-7. PubMed ID: 21526501
[TBL] [Abstract][Full Text] [Related]
9. Frequent expression of soluble Fas and Fas ligand in Chinese stomach cancer and its preneoplastic lesions.
Li H; Liu N; Guo L; Li JW; Liu J
Int J Mol Med; 2000 May; 5(5):473-6. PubMed ID: 10762649
[TBL] [Abstract][Full Text] [Related]
10. Significance of Fas and FasL protein expression in cardiac carcinoma and local lymph node tissues.
Li Y; Xu DF; Jiang D; Zhao J; Ge JF; Zheng SY
Int J Clin Exp Pathol; 2015; 8(9):11915-20. PubMed ID: 26617948
[TBL] [Abstract][Full Text] [Related]
11. The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray.
Gomes TS; Oshima CT; Segreto HR; Barrazueta LM; Costa HO; Lima FO; Forones NM; Ribeiro DA
Pathol Res Pract; 2011 Oct; 207(10):613-7. PubMed ID: 21856093
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer.
Ohno S; Tachibana M; Shibakita M; Dhar DK; Yoshimura H; Kinugasa S; Kubota H; Masunaga R; Nagasue N
Ann Surg Oncol; 2000 Dec; 7(10):750-7. PubMed ID: 11129423
[TBL] [Abstract][Full Text] [Related]
13. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
14. Induction of Fas-mediated apoptosis in a human renal epithelial cell line by interferon-gamma: involvement of Fas-mediated apoptosis in acute renal rejection.
Akasaka Y; Ishikawa Y; Kato S; Ishii T; Masuda T; Fujita K; Yamada T; Kawamura S
Mod Pathol; 1998 Nov; 11(11):1107-14. PubMed ID: 9831209
[TBL] [Abstract][Full Text] [Related]
15. Transitional cell carcinoma expresses high levels of Fas ligand in vivo.
Lee SH; Lee JY; Park WS; Kim SY; Jang JJ; Yoo NJ
BJU Int; 1999 Apr; 83(6):698-702. PubMed ID: 10233582
[TBL] [Abstract][Full Text] [Related]
16. The Btk-dependent PIP5K1γ lipid kinase activation by Fas counteracts FasL-induced cell death.
Rossin A; Lounnas N; Durivault J; Miloro G; Gagnoux-Palacios L; Hueber AO
Apoptosis; 2017 Nov; 22(11):1344-1352. PubMed ID: 28879546
[TBL] [Abstract][Full Text] [Related]
17. Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.
Das SN; Khare P; Singh MK; Sharma SC
Indian J Med Res; 2011 Jul; 134(1):54-60. PubMed ID: 21808135
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of Fas ligand expression in normal human tissues.
Lee SH; Shin MS; Park WS; Kim SY; Dong SM; Lee HK; Park JY; Oh RR; Jang JJ; Lee JY; Yoo NJ
APMIS; 1999 Nov; 107(11):1013-9. PubMed ID: 10598873
[TBL] [Abstract][Full Text] [Related]
19. Regulative effect of IFN-gamma on the Fas/Fas L system of cholangiocarcinoma cells.
Li Z; Wang J; Tang C; Wang X; Zou S
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Dec; 36(7):495-8. PubMed ID: 12411152
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue.
Zhao XH; Gu SZ; Tian HG; Quan P; Pan BR
World J Gastroenterol; 2005 Jul; 11(25):3846-9. PubMed ID: 15991280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
